Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies

To report the clinical performance of massively parallel sequencing‐based non‐invasive prenatal testing (NIPT) in detecting trisomies 21, 18 and 13 in over 140 000 clinical samples and to compare its performance in low‐risk and high‐risk pregnancies.

[1]  Wei-Mou Zheng,et al.  Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies , 2012, BMC Medical Genomics.

[2]  C. Cantor,et al.  Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. , 2011, American journal of obstetrics and gynecology.

[3]  C. Struble,et al.  The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[4]  Hui Jiang,et al.  Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X , 2012, Prenatal diagnosis.

[5]  C. Cantor,et al.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.

[6]  Ping Liu,et al.  A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing , 2013, Prenatal diagnosis.

[7]  J. Canick,et al.  The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies , 2013, Prenatal diagnosis.

[8]  Hanmin Lee,et al.  Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[9]  Peiyong Jiang,et al.  Noninvasive Prenatal Diagnosis of Fetal Trisomy 18 and Trisomy 13 by Maternal Plasma DNA Sequencing , 2011, PloS one.

[10]  Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. , 2012, Obstetrics and gynecology.

[11]  A. Siddiqui,et al.  Single-Nucleotide Polymorphism–Based Noninvasive Prenatal Screening in a High-Risk and Low-Risk Cohort , 2014, Obstetrics and gynecology.

[12]  Amin R. Mazloom,et al.  Non-Invasive Prenatal Chromosomal Aneuploidy Testing - Clinical Experience: 100,000 Clinical Samples , 2014, PloS one.

[13]  Matthew Rabinowitz,et al.  Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. , 2014, American journal of obstetrics and gynecology.

[14]  H. C. Fan,et al.  Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.

[15]  F. Song,et al.  Evaluating non-randomised intervention studies. , 2003, Health technology assessment.

[16]  L. Dugoff,et al.  Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis , 2013, Prenatal diagnosis.

[17]  A. Kurjak,et al.  Noninvasive Prenatal Testing for Fetal Aneuploidy , 2013 .

[18]  Arnold Oliphant,et al.  Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[19]  Stanley F. Nelson,et al.  DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study , 2012, Genetics in Medicine.

[20]  Kang Zhang,et al.  DNA sequencing versus standard prenatal aneuploidy screening. , 2014, The New England journal of medicine.

[21]  H. Cuckle,et al.  Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. , 2012, Obstetrics and gynecology.

[22]  A. Rudnicka,et al.  First-trimester or second-trimester screening, or both, for Down's syndrome. , 2005, The New England journal of medicine.

[23]  Yijun Song,et al.  Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population , 2013, Prenatal diagnosis.

[24]  Kypros H Nicolaides,et al.  Screening for fetal aneuploidies at 11 to 13 weeks , 2011, Prenatal diagnosis.

[25]  K. Choy,et al.  Secondary findings from non‐invasive prenatal testing for common fetal aneuploidies by whole genome sequencing as a clinical service , 2013, Prenatal diagnosis.

[26]  S. Cheung,et al.  Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center , 2014 .

[27]  Yama W. L. Zheng,et al.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.

[28]  R. Rava,et al.  Initial clinical laboratory experience in noninvasive prenatal testing for fetal aneuploidy from maternal plasma DNA samples , 2013, Prenatal diagnosis.

[29]  E. Hardisty,et al.  Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease , 2013, Prenatal diagnosis.

[30]  Matthew Rabinowitz,et al.  Non-invasive prenatal aneuploidy testing at chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci , 2013 .

[31]  S. Nelson,et al.  DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study , 2011, Genetics in Medicine.

[32]  Tak Y. Leung,et al.  Maternal Plasma Fetal DNA Fractions in Pregnancies with Low and High Risks for Fetal Chromosomal Aneuploidies , 2014, PloS one.

[33]  Lin Tang,et al.  Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. , 2011, American journal of obstetrics and gynecology.

[34]  Argyro Syngelaki,et al.  Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. , 2012, American journal of obstetrics and gynecology.

[35]  R. Rava,et al.  Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. , 2013, American journal of human genetics.

[36]  Jian Wang,et al.  Clinical application of massively parallel sequencing‐based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11 105 pregnancies with mixed risk factors , 2012, Prenatal diagnosis.

[37]  Xun Xu,et al.  Effective Noninvasive Zygosity Determination by Maternal Plasma Target Region Sequencing , 2013, PloS one.

[38]  N J Wald,et al.  First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). , 2003, Health technology assessment.

[39]  I. Janssen,et al.  Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells , 2012, Expert opinion on biological therapy.

[40]  D. Weaver,et al.  Positive cell-free fetal DNA testing for trisomy 13 reveals confined placental mosaicism , 2013, Genetics in Medicine.

[41]  K. Nicolaides,et al.  Implementation of maternal blood cell‐free DNA testing in early screening for aneuploidies , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[42]  K. Ormond,et al.  Noninvasive Prenatal Testing/Noninvasive Prenatal Diagnosis: the Position of the National Society of Genetic Counselors , 2013, Journal of Genetic Counseling.

[43]  M. Lutgendorf,et al.  Noninvasive prenatal testing: limitations and unanswered questions , 2013, Genetics in Medicine.